Evusheld Reduces COVID-19 Disease Severity Among Unvaccinated Adults

JAMA. 2022 Jul 26;328(4):322. doi: 10.1001/jama.2022.12178.
No abstract available

MeSH terms

  • Adult
  • Antibodies, Monoclonal* / therapeutic use
  • Antibodies, Neutralizing* / therapeutic use
  • Antiviral Agents* / therapeutic use
  • COVID-19* / therapy
  • Drug Combinations
  • Humans
  • Patient Acuity
  • Severity of Illness Index
  • Vaccination

Substances

  • Antibodies, Monoclonal
  • Antibodies, Neutralizing
  • Antiviral Agents
  • Drug Combinations
  • cilgavimab and tixagevimab drug combination